share_log

Altimmune | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TIAA-CREF Investment Management, LLC(2.88%),Teachers Advisors, LLC(0.32%), etc.

SEC announcement ·  Feb 15 01:07
Summary by Futu AI
On December 31, 2023, Altimmune Inc., a biopharmaceutical company, was the subject of a Schedule 13G filing with the Securities and Exchange Commission (SEC), indicating changes in ownership by significant investment entities. Nuveen Asset Management, LLC (NAM), TIAA-CREF Investment Management, LLC (TCIM), and Teachers Advisors, LLC (TAL), all based in Delaware, reported their respective holdings in Altimmune's common stock. NAM reported beneficial ownership of 6,679 shares, TCIM reported 1,549,364 shares, and TAL reported 171,273 shares, with all shares being acquired in the ordinary course of business. The combined holdings represent a total of 3.21% of Altimmune's common stock. The filing, dated February 14, 2024, confirms that the shares were not acquired with the intention of changing or influencing the control of Altimmune Inc. The principal executive offices of Altimmune Inc. are located at 910 Clopper Road, Suite 201S, Gaithersburg, MD, United States.
On December 31, 2023, Altimmune Inc., a biopharmaceutical company, was the subject of a Schedule 13G filing with the Securities and Exchange Commission (SEC), indicating changes in ownership by significant investment entities. Nuveen Asset Management, LLC (NAM), TIAA-CREF Investment Management, LLC (TCIM), and Teachers Advisors, LLC (TAL), all based in Delaware, reported their respective holdings in Altimmune's common stock. NAM reported beneficial ownership of 6,679 shares, TCIM reported 1,549,364 shares, and TAL reported 171,273 shares, with all shares being acquired in the ordinary course of business. The combined holdings represent a total of 3.21% of Altimmune's common stock. The filing, dated February 14, 2024, confirms that the shares were not acquired with the intention of changing or influencing the control of Altimmune Inc. The principal executive offices of Altimmune Inc. are located at 910 Clopper Road, Suite 201S, Gaithersburg, MD, United States.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.